GeminIQ Website Logo

Viewing HCA free

Subscribe for full history, 90+ metrics, screener, watchlist...

HCA Healthcare, Inc.

HCA

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
9401,0409979391,0601,9332,8888311,284935891862
Accounts Receivable Net Current
11,32410,86710,42810,45911,08810,7519,91510,23910,0449,9589,1828,713
Inventory Net
1,6811,6521,7341,7921,7941,7381,7761,8001,9032,0212,0302,050
Other Assets Current
2,1072,2242,1262,3732,3161,9922,0832,3032,0512,0132,1912,263
Assets Current
16,05215,78315,28515,56316,25816,41416,66215,17315,28214,92714,29413,888
Property And Equipments
Land
-3,415---3,295---3,120--
Buildings And Improvements Gross
-23,726---22,691---21,560--
Machinery And Equipment Gross
-36,989---34,670---31,998--
Construction In Progress Gross
-2,145---1,858---1,870--
Property Plant And Equipment Gross
67,36566,27565,48964,38863,68062,51461,75060,62559,44058,54857,77256,667
Accumulated Depreciation Depletion And Amortizatio…
-35,893-35,134-34,921-34,265-33,942-33,100-32,703-31,986-31,344-30,833-30,655-30,023
Property Plant And Equipment Net
31,47231,14130,56830,12329,73829,41429,04728,63928,09627,71527,11726,644
Available For Sale Securities Debt Securities Nonc…
387485573531550569553483471477382384
Equity Method Investments
615633654654657662705702736756739731
Intangible Assets Net Including Goodwill
10,50410,29310,27510,27310,23710,0939,9829,9639,9679,9459,7789,641
Operating Lease Right Of Use Asset
2,0942,1302,1152,1562,1322,1312,2012,1792,2112,2072,0792,110
Other Assets Noncurrent
326255277236226230309240199184200196
Assets
61,45060,72059,74759,53659,79859,51359,45957,37956,96256,21154,58953,594
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
4,8064,6594,5524,2504,4884,2764,2354,0294,7354,2334,1393,823
Accrued Salaries Current
2,0222,5252,2942,0721,8572,3042,1641,9931,7592,1271,9121,776
Other Accrued Liabilities Current
3,8984,2774,9404,5133,7673,8993,8193,7053,6193,8713,8033,551
Long Term Debt Current
----3,5194,6984,6824,5743,0282,4242,5532,395
Debt Current
8,5324,8896,1105,104-4,698------
Liabilities Current
19,25816,35017,89615,93913,63115,17714,90014,30113,14112,65512,40711,545
Long Term Debt Noncurrent
39,49141,60338,40139,37941,05738,33338,28336,30637,16337,16936,79336,537
Operating Lease Liability Noncurrent
1,8221,8531,8381,8811,8601,8631,9241,8941,9121,9031,7761,806
Stockholders Equity Inclu…
Common Stock Value Outstanding
222223333333
Accumulated Other Comprehensive Income Loss Net Of…
-327-305-317-309-357-387-378-433-433-425-491-456
Retained Earnings Accumulated Deficit
-5,978-5,724-5,020-4,087-3,164-2,115-1,807-1,170-1,185-1,352-1,989-1,850
Stockholders Equity
-6,303-6,027-2,159-1,238-438555-2,182-1,600-1,6151,060357461
Minority Interest
3,3253,2563,1763,1563,0813,0542,9682,9392,8852,8342,8342,764
Liabilities And Stockholders Equity
61,45060,72059,74759,53659,79859,51359,45957,37956,96256,21154,58953,594
Deferred Finance Costs Noncurrent Net
433436416429432369378371381333341349
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
1,8001,8001,8001,8001,8001,8001,8001,8001,8001,8001,8001,800
Shares Outstanding
223225230236243250255259263266269273

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-9.36%-13.54%-14.46%---------
20259.78%10.26%5.48%11.22%15.59%23.30%5.18%1.47%0.68%6.13%-5.88%-13.61%
20243.19%9.95%4.52%8.38%12.99%16.03%-9.42%-15.19%-13.28%4.41%5.12%10.29%
2023---1.44%-6.14%-10.29%11.08%22.18%27.51%5.45%6.78%-0.05%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.83
0.97
0.85
0.98
1.19
1.08
1.12
1.06
1.16
1.18
1.15
1.20
Quick Ratio
0.75
0.86
0.76
0.86
1.06
0.97
1.00
0.94
1.02
1.02
0.99
1.03
Working Capital
-3.21B
-567.00M
-2.61B
-376.00M
2.63B
1.24B
1.76B
872.00M
2.14B
2.27B
1.89B
2.34B
Leverage & Debt
Debt to Equity
-3.06
-5.90
-8.29
-12.87
-31.12
27.35
-6.83
-8.94
-8.14
11.94
34.75
25.04
Interest Coverage TTM
5.38
5.37
4.68
4.54
4.67
4.70
4.87
4.80
4.63
4.54
4.85
4.95
Debt Ratio
0.31
0.27
0.30
0.27
0.23
0.26
0.25
0.25
0.23
0.23
0.23
0.22
Efficiency & Turnover
Asset Turnover TTM
1.26
1.26
1.25
1.24
1.23
1.22
1.22
1.23
1.22
1.20
1.19
1.18
Days Sales Outstanding TTM
53.54
52.19
49.92
51.96
53.87
53.53
50.06
50.61
51.16
52.95
51.24
51.11
Receivables Turnover TTM
6.82
6.99
7.31
7.02
6.78
6.82
7.29
7.21
7.14
6.89
7.12
7.14
Per Share Metrics
Diluted EPS TTM
35.42
32.49
25.90
23.75
23.17
22.00
22.84
21.76
20.41
18.96
20.04
20.04
Free Cash Flow Per Share TTM
35.45
32.54
34.76
30.49
20.04
21.81
22.90
18.72
20.54
17.21
16.14
17.97
Dividend Per Share TTM
3.05
2.87
2.93
2.86
2.77
2.67
2.67
2.60
2.54
2.43
2.42
2.39
Margin Metrics
Gross Profit Margin TTM
97.01%
97.03%
97.04%
97.03%
97.07%
97.08%
97.09%
97.09%
97.05%
97.02%
96.99%
96.99%
Operating Profit Margin TTM
12.82%
13.01%
12.50%
12.08%
12.02%
12.07%
12.55%
12.38%
12.04%
11.86%
13.72%
14.11%
Net Profit Margin TTM
10.51%
10.29%
8.23%
7.90%
8.07%
8.16%
8.53%
8.41%
8.20%
8.07%
8.74%
9.00%
Growth Metrics
Net Revenue Growth (1Y)
6.71%
7.08%
6.82%
6.37%
7.30%
8.67%
10.23%
10.38%
9.59%
7.86%
5.62%
3.02%
Net Income Growth (1Y)
38.93%
35.10%
3.07%
0.00%
5.65%
9.88%
7.56%
3.07%
-1.28%
-7.11%
-10.11%
-25.46%
EPS Growth (1Y)
53.44%
47.79%
13.63%
9.19%
13.14%
15.75%
13.59%
8.33%
3.38%
-0.99%
-5.21%
-20.56%
Valuation Metrics
P/E TTM
13.15
14.13
16.14
15.84
14.64
13.33
17.35
14.39
15.86
13.80
11.83
14.60
P/B TTM
-16.75
-39.69
-45.75
-73.51
-193.13
138.33
-47.20
-51.67
-53.71
68.27
182.96
176.54
P/S TTM
1.38
1.45
1.33
1.25
1.18
1.09
1.48
1.21
1.30
1.11
1.03
1.31
Market Cap
105.60B
109.99B
98.77B
91.01B
84.59B
76.77B
103.00B
82.68B
86.74B
72.37B
65.32B
81.38B
Enterprise Value
152.68B
155.44B
142.28B
134.55B
128.11B
117.87B
143.08B
122.72B
125.64B
111.02B
103.77B
119.45B
Calculated Values
Free Cash Flow TTM
7.93B
7.69B
8.10B
7.29B
4.95B
5.64B
5.88B
4.89B
5.43B
4.69B
4.38B
4.93B
Net Debt
47.08B
45.45B
43.51B
43.54B
43.52B
41.10B
40.08B
40.05B
38.91B
38.66B
38.46B
38.07B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-02-18Sale
Owner: Mcalevey, Michael R
Title: EVP & Chief Legal & Admin Off.
Shares: 1,694
Price/Share: $533.37
Value: $903,528.78
Shares Owned: 8,853
Relationship: Officer
Ownership: Direct
2026-02-11Sale
Owner: Wyatt, Christopher F.
Title: SVP & Controller
Shares: 4,000
Price/Share: $505.00
Value: $2,020,000.00
Shares Owned: 44,379
Relationship: Officer
Ownership: Direct
2026-02-11Sale
Owner: Berres, Jennifer
Title: SVP & Chief Human Res. Officer
Shares: 8,020
Price/Share: $514.58
Value: $4,126,931.60
Shares Owned: 11,993
Relationship: Officer
Ownership: Direct
2026-02-03Sale
Owner: Hazen, Samuel N
Title: CEO
Shares: 42,877
Price/Share: $499.99
Value: $21,438,071.23
Shares Owned: 32,276
Relationship: Director,Officer
Ownership: Direct
2026-02-03Sale
Owner: Cuffe, Michael S.
Title: EVP and Chief Clinical Officer
Shares: 1,500
Price/Share: $498.09
Value: $747,135.00
Shares Owned: 30,003
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
55.28%
Inst. Shares: 123,605,708
Shares Outstanding: 223,588,000
2025-12-31
55.56%
Inst. Shares: 131,351,329
Shares Outstanding: 236,413,000
2025-09-30
56.72%
Inst. Shares: 132,098,525
Shares Outstanding: 232,891,000
2025-06-30
58.17%
Inst. Shares: 139,120,628
Shares Outstanding: 239,173,000
2025-03-31
58.06%
Inst. Shares: 143,375,058
Shares Outstanding: 246,936,000

HCA Healthcare, Inc. (HCA) — SEC Financial Statements & Analysis

HCA Healthcare, Inc. (HCA) is a services-general medical & surgical hospitals, nec company. HCA Healthcare, Inc. trades on NYSE as: HCA. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), HCA Healthcare, Inc. reported a 6.71% year-over-year revenue growth, a Gross Profit Margin of 97.01% (TTM), a Debt-to-Equity ratio of -3.06x, a Price-to-Sales (P/S) ratio of 1.38x (TTM), a Price-to-Book (P/B) ratio of -16.75x (TTM), at a market cap of $105.60B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
6.71%
Gross Profit Margin TTM
97.01%
Debt To Equity
-3.06x
P/S TTM
1.38x
P/B TTM
-16.75x
Market Cap
$105.60B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is HCA Healthcare, Inc. in?

HCA Healthcare, Inc. (HCA) operates in the Services-General Medical & Surgical Hospitals, NEC industry.

What is HCA's market cap?

HCA Healthcare, Inc. (HCA) has a market capitalization of $105.60B as of 2026-03-31.

What is HCA's P/E ratio?

HCA Healthcare, Inc. (HCA)'s trailing twelve month P/E ratio is 13.15x as of 2026-03-31.

What exchange does HCA trade on?

HCA Healthcare, Inc. (HCA) trades on the NYSE.

Wall Street's data.
Main Street's price.